loader2
Partner With Us NRI

Apr 24, 2024


Category

Equity

AUM (Cr.)

7,125.28

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.83

Sharpe Ratio

29.33

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (Bonus) -0.33 23.49 50.73 15.66 22.39 20.7
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS 4.02 25.41 45.44 22.2 19.41 18.32
Category Rank 7/6 5/6 7/6 8/6 6/6 6/6
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (G) 10.2233 4.68 33.83 0.00 0.00 453.89 2.44 500.00 invest
Nippon India Taiwan Equity Fund (IDCW) 10.2233 4.68 33.83 0.00 0.00 453.89 2.44 500.00 invest
DSP Natural Resources & New Energy Fund (G) 87.2650 2.10 47.43 23.53 21.60 990.34 0.00 100.00 invest
DSP Natural Resources & New Energy Fund (IDCW) 30.2480 2.10 47.43 20.26 19.43 990.34 0.00 100.00 invest
Kotak Technology Fund - Regular (IDCW) 9.6700 -0.69 0.00 0.00 0.00 303.02 2.42 100.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Mar 31, 2024 1,062.49 14.91 2.70
Equity-Lupin Mar 31, 2024 598.81 8.40 -0.26
Equity-Cipla Mar 31, 2024 464.05 6.51 1.12
Equity-Apollo Hospitals Mar 31, 2024 412.43 5.79 4.18
Equity-Dr Reddy`s Labs Mar 31, 2024 338.70 4.75 -4.15
Equity-Gland Pharma Mar 31, 2024 313.69 4.40 4.49
Equity-Divi`s Lab. Mar 31, 2024 310.36 4.36 -1.25
Equity-Zydus Lifesci. Mar 31, 2024 297.53 4.18 5.27
Equity-J B Chem & Pharm Mar 31, 2024 245.39 3.44 5.67
Equity-Abbott India Mar 31, 2024 234.30 3.29 -4.62

latest news

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 April 2024 as the record date for...

Apr 09, 2024 09:19

Nippon India MF Announces change in fund managers under its schemes

Nippon India Mutual Fund has announced the following change in the fund man...

Apr 06, 2024 11:35

Nippon India Small Cap Fund Announces change in exit load structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Mar 20, 2024 16:29

Nippon India Fixed Maturity Plan - XLVI - Series 5 Announces Extension of NFO period

Nippon India Mutual Fund has announced that New Fund Offer (NFO) Period of ...

Mar 16, 2024 12:32

Nippon India Mutual Fund Announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes

Nippon India Mutual Fund has announced 29 February 2024 as the record date ...

Feb 27, 2024 15:32

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 February 2024 as the record date ...

Feb 09, 2024 09:14

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (Bonus)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com